Pasithea Therapeutics is a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Pasithea Therapeutics
Pasithea is developing new molecular entities for the treatment of psychiatric disorders. Additionally, Pasithea currently provides ketamine-assisted therapy in clinics and at home in the US. Recently, the company partnered with ZEN Healthcare in the UK to provide ketamine-assisted therapy across its network of clinics in London.
Activities
B2B
B2C
Pharmaceutical
Biotech
Clinic
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Company News
Pasithea Therapeutics Corp’s (NASDAQ: KTTA) Subsidiary Pasithea Clinics Administers First Intravenous Ketamine Therapy (, 15 November 2021)Pasithea Therapeutics Brings New Depression Treatments To London (, 22 November 2021)
Pasithea Therapeutics Opens Second Ketamine Therapy Clinic in the United Kingdom (, 21 December 2021)
Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint (, 17 November 2021)